A noninvasive skin-stripping test has been developed to differentiate between eczema and psoriasis when diagnosing inflammatory skin diseases.
Researchers from the University of Queensland (Australia) have discovered a unique biomarker common to multiple cancers that has the potential to change the way early stage cancer is diagnosed.
Researchers at the CEU Cardenal Herrera University (Valencia, Spain) have discovered the three most efficient types of salivary biomarkers for the early detection of oral cancer.
A team of researchers from Duke University (NC, USA) have discovered a marker that could be used to detect autologous blood doping in athletes.
Richard Hucker (A4P Codescribes key trends, challenges and what the future may hold for bioanalytical outsourcing.
Find out more about what is important when outsourcing, in this interview with Lee Abberley (GSK).
Flow cytometry is increasingly recognized as an invaluable technology in biomarker research. Owing to its multiparametric nature it can provide highly detailed information on any single cell in a heterogeneous population. Find out more in this review from Bioanalysis.
A team from the UC Davis MIND Institute and NeuroPointDX (CA, USA) have developed a metabolic blood test that could identify approximately 17% of children with autism spectrum disorder (ASD).
As part of our Spotlight on the validation of biomarkers, we conducted a survey and compared the results to previous data. Find out more about the key trends, challenges and future potential for biomarker R&D in this informative infographic.
Webinar available to view on demand. Accurate and precise biomarker measurement is critical to identifying diagnostic markers and druggable targets. Learn how quantitative mass spectrometry ensures proper biomarker measurement and characterization.